NCT03311815View on ClinicalTrials.gov

Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.

CompletedOBSERVATIONAL

Enrollment

900

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

October 15, 2019

Study Completion Date

October 15, 2019

Conditions

Acute Myeloid Leukemia

Interventions

DIAGNOSTIC_TEST

NGS techniques

Using NGS techniques we will detect the recurrently mutated genes in AML to establish the biological role of each mutation

Trial Locations (7)

Unknown

Hospital Reina Sofía, Córdoba

Hospital Dr. Negrín, Las Palmas de Gran Canaria

Hospital 12 de Octubre, Madrid

Clínica Universidad de Navarra, Pamplona

Hospital General Universitario, Salamanca

Hospital Virgen del Rocío, Seville

Hospital Universitari i Politècnic La Fe, Valencia

All Listed Sponsors

lead

PETHEMA Foundation

OTHER

NCT03311815 - Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia. | Biotech Hunter | Biotech Hunter